Arpida AG

Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products.

Arpida AG is a biopharmaceutical company that focused on the discovery and development of novel products for the treatment of bacterial infections.

Number of Funding Rounds

Total Funding Amount

1

Fr40M

Arpida AG has raised a total of Fr40M in funding over 2 rounds. Their latest funding was raised on Oct 23, 2000 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 23, 2000	Series B	Fr40M	1	—	—	Detail

Number of Lead Investors

Number of Investors

—

1

Arpida AG is funded by 1 investors. Partners Group are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partners Group	—	Series B